"The Effect of The Combination Therapy of Statin and SGLT2i in The Treatment of Ischemic Heart Disease"
NCT06520891 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 90
Last updated 2025-09-11
Summary
correlate the serum level of statin and SGLT2i when given as polytherapy with HPLC in ischemic heart failure patients and their laboratory tests (cholesterol, LDL, HDL and TG...)
Conditions
- 2 Drugs Are Statin and SGLT2i
Interventions
- DRUG
-
Statin and SGLT2i
Statin as atrovastatin SGLT2i as dapagliflozin
Sponsors & Collaborators
-
Fayoum University
lead OTHER
Eligibility
- Min Age
- 50 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-06-01
- Primary Completion
- 2025-11-30
- Completion
- 2025-12-30
Countries
- Egypt
Study Locations
More Related Trials
-
PCSK9 Inhibitors in the Treatment of Calcific Aortic Stenosis
NCT07256197 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Effect of PCSK9 Inhibitors on Coronary Atherosclerotic Plaques Derived From Optical Coherence Tomography
NCT06520904 ·Status: RECRUITING ·Phase: PHASE4
-
Assessment of the Effects of Atorvastatin Therapy on Myocardial Deformation Characteristics, in Patients With STEMI
NCT02590653 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Short-term Intensive Statin Therapy on Lipid Levels
NCT07344610 ·Status: RECRUITING
-
Intensive Statin Therapy in PCI Patient With Acute Coronary Syndrome
NCT01372839 ·Status: UNKNOWN ·Phase: PHASE4
-
Early Statin-Ezetimibe Combination vs. Statin Monotherapy in Stroke With Atherosclerosis
NCT07307989 ·Status: RECRUITING ·Phase: PHASE2
-
Effect of Statin Preloading in STEMI in Improving PCI Outcomes
NCT04974814 ·Status: UNKNOWN ·Phase: NA
-
Statin Effect on Arrhythmogenic Cardiomyopathy Disease Progression (SEARCH)
NCT06922994 ·Status: RECRUITING ·Phase: PHASE2
-
Statin Therapy to Improve Medication Adherence
NCT01894217 ·Status: COMPLETED ·Phase: PHASE1
-
Low-dose PCSK9 Inhibitor Combined With Stains on Serum Lipids in Chinese Population With Acute Coronary Syndrome
NCT05298475 ·Status: UNKNOWN ·Phase: PHASE4
-
Statin Monotherapy or Statins in Combination With Ezetimibe in Patients for Prevention of CVD
NCT04895098 ·Status: COMPLETED
-
Chronic Coronary Syndrome Real Practice and Guidelines
NCT06684366 ·Status: ACTIVE_NOT_RECRUITING
-
Effects of Intensive Statin Treatment on Left Ventricular Function
NCT01936103 ·Status: UNKNOWN ·Phase: PHASE4
-
The Clinical Effect of Intensive Statin Therapy in STEMI Patients Before Emergency PCI
NCT01334671 ·Status: UNKNOWN ·Phase: PHASE3
-
Effective Dose of Statin Post PCI
NCT04923152 ·Status: COMPLETED ·Phase: NA
-
Physical and Chemical Study of Atherosclerosis Mechanisms
NCT01700075 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of a Decision Aid About Statin Use in Patients With Type 2 Diabetes Mellitus
NCT00217061 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of Colchicine on Inflammation in ACS Patients
NCT06054100 ·Status: COMPLETED ·Phase: PHASE3
-
PCSK 9 Inhibitor Added to High-Intensity Statin Therapy to Prevent Cardiovascular Events in Patients With ACS After PCI
NCT05457582 ·Status: RECRUITING ·Phase: NA
-
The Association of Statins on Cardiorespiratory Fitness and Exercise Adaptation
NCT04986241 ·Status: COMPLETED
-
Familial Atherosclerosis Treatment Study
NCT00000512 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Combination Therapy of Moderate-intensity Statin and Ezetimibe Compared to High-intensity Statin
NCT04080310 ·Status: COMPLETED ·Phase: PHASE4
-
Mechanism and Intervention Research of Atherosclerosis
NCT05437107 ·Status: COMPLETED
-
Efficacy Study of Pioglitazone and Atorvastatin Combination Therapy in Treating Subjects With Elevated Risk for Cardiovascular Disease
NCT00770575 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of PCSK9 Inhibitor on Retinal Microvessels in Patients With Coronary Heart Disease After Intensive Lipid-lowering Therapy
NCT05802108 ·Status: UNKNOWN ·Phase: PHASE4